We immunochemically studied p16 INK4a Urothelial carcinoma of the urinary bladder is one of the most frequent malignancies in industrialized countries. 1 Although the incidence of urothelial carcinoma in Japan is lower than in other industrialized countries, it is the 12th and 13th most frequently diagnosed malignancy in men and women, respectively, and more than 6,000 people die of the disease per year. 2 Based on the 2004 World Health Organization classification of tumors of the urinary system, urothelial carcinoma has 2 subtypes based on cellular and structural atypia, low-and high-grade types, and 2 subtypes based on invasion, noninfiltrating and infiltrating types. 3 Low-grade urothelial carcinoma, which has an incidence of 70% to 80%, is usually noninfiltrating and has an excellent prognosis but shows frequent relapse. 3 About 30% of these recurrent tumors may show progression to higher grade with stromal invasion. 3,4 High-grade noninfiltrating urothelial carcinoma, including papillary and flat types, namely carcinoma in situ (CIS), often progresses to infiltrating carcinoma. Highgrade infiltrating carcinoma usually has a poor prognosis.
We immunochemically studied p16 INK4a (16/20 [80%] ) of p16 INK4a 
overexpression in high-grade carcinomas was noted in cytologic samples. Immunocytologic analysis of p16 INK4a expression in cytologic samples is a useful ancillary tool for detection of urothelial carcinoma with infiltrating potential.
Urothelial carcinoma of the urinary bladder is one of the most frequent malignancies in industrialized countries. 1 Although the incidence of urothelial carcinoma in Japan is lower than in other industrialized countries, it is the 12th and 13th most frequently diagnosed malignancy in men and women, respectively, and more than 6,000 people die of the disease per year. 2 Based on the 2004 World Health Organization classification of tumors of the urinary system, urothelial carcinoma has 2 subtypes based on cellular and structural atypia, low-and high-grade types, and 2 subtypes based on invasion, noninfiltrating and infiltrating types. 3 Low-grade urothelial carcinoma, which has an incidence of 70% to 80%, is usually noninfiltrating and has an excellent prognosis but shows frequent relapse. 3 About 30% of these recurrent tumors may show progression to higher grade with stromal invasion. 3, 4 High-grade noninfiltrating urothelial carcinoma, including papillary and flat types, namely carcinoma in situ (CIS), often progresses to infiltrating carcinoma. Highgrade infiltrating carcinoma usually has a poor prognosis.
Treatment options for urothelial carcinoma vary depending on factors such as subtype, stage, and tumor size. Usually, low-grade noninfiltrating carcinoma is treated by transurethral resection (TUR); high-grade noninfiltrating or early infiltrating carcinoma is treated by TUR followed by bacillus Calmette-Guérin (BCG) therapy and chemotherapy; and total cystectomy with or without chemotherapy is used to treat advanced-stage infiltrating carcinoma. 5 From the therapeutic point of view, it is important to detect high-grade malignancy and invasion potential.
Urine cytology is the primary mode of detecting and monitoring urothelial carcinoma. Cytologic specificity is relatively high for the detection of urothelial carcinoma, but sensitivity is low, particularly in low-grade urothelial carcinoma. Diagnosis of urothelial carcinoma by fluorescence in situ hybridization (FISH) has been popular because of its comparable specificity and higher sensitivity than urine cytology. [6] [7] [8] [9] [10] [11] [12] [13] The Vysis UroVysion (Quest Diagnostics, Madison, NJ) FISH method can detect deletion of locus 9p21 and polysomy of chromosomes 3, 7, and 17. The locus 9p21 contains the CDK2/p16 INK4a gene, which encodes cyclin-dependent kinase (CDK) inhibitor and regulates cell proliferation.
Loss and overexpression of p16 INK4a protein can affect carcinogenesis and progression of malignancy from various organs, such as the uterine cervix. [14] [15] [16] [17] [18] [19] [20] 
Materials and Methods

Cases
Cytologic Diagnosis
Cytologic samples were classified into 4 groups: 1, mild cellular atypia (probably benign); 2, moderate cellular atypia (indeterminate for malignancy); 3, severe cellular atypia ("suspicious" of malignancy); and 4, malignancy. The cytologic diagnosis of 116 samples comprised 32 in group 1, 50 in group 2, 12 in group 3, and 22 in group 4.
Immunohistochemical and Immunocytochemical Studies
For immunohistochemical analysis, 4-μm-thick tissue sections on silane-coated glass slides were prepared. Urine cytologic samples were stained with Papanicolaou stain after centrifugation (1,500 rpm for 5 minutes) and fixed in YM's Fluid Fixative (Muto Pure Chemicals, Tokyo, Japan) on silanecoated glass slides. After cytologic diagnosis, the samples were immunostained. p16 INK4a immunostaining of the histologic and cytologic samples was performed using a CINtec p16 INK4a Research Kit (clone E6H4; DakoCytomation, Glostrup, Denmark) with a DAKO Autostainer Plus (DakoCytomation Colorado, Fort Collins), after a high-temperature antigen unmasking technique using Epitope Retrieval Solution (DakoCytomation, Glostrup) (10 minutes, 95°C).
The intensity of the immunoreactivity detected in the nuclei and/or cytoplasm of atypical cells was scored by the number of positive cells, as follows: negative (0), no discernible staining or fewer than 5% positive cells; 1+, 5% to 20% positive cells; 2+, 21% to 70% positive cells; 3+, more than 71% positive cells with strong intensity, usually in nuclei and the cytoplasm. Histologic and cytologic samples showing 2+ or 3+ immunoreactivity were considered to show overexpression of p16 INK4a .
Statistical Analysis
Statistical analysis was performed using the χ 2 test for independence. A P value of less than .05 was considered as statistically significant. (P = .002; χ 2 test). Also, the incidence of p16 INK4a overexpression between 2 groups was significantly different, except between groups 3 and 4 (groups 1 and 2, P = .02; 1 and 3, P = .0001; 1 and 4, P = .00004; 2 and 3, P = .05; 2 and 4, P = .01; and 3 and 4, P = .69; χ 2 test).
Results
Expression of p16 INK4a in Histologic Sections
Comparison Between Nonneoplastic and Neoplastic Lesions
Comparison of p16 INK4a Overexpression Between Cytologic and Histologic Diagnoses
Diagnosis in most cases in groups 3 and 4 was confirmed by histologic examination, while only 7 cases in group 2 in which malignancy was suspected clinically were diagnosed histologically. Thirty-eight cases were studied immunochemically for p16 INK4a 
Discussion
Immunohistochemical and cytogenetic studies have shown aberrant expression of various cell-cycle-related proteins based on losses and gains of chromosomal regions in bladder cancer. 4, [27] [28] [29] Human p16 INK4a , the gene of which is located on the 9p21 locus, is one of the CDK inhibitors that regulates the cell cycle and prevents abnormal cell proliferation. Aberration of p16 INK4a expression has also been considered as a cause of carcinogenesis and tumor progression in urothelial carcinoma. 4, [32] [33] [34] [35] [36] In most previous studies, aberration of p16 INK4a AIHGUC, advanced infiltrating urothelial carcinoma (pT2-4); AUS, atypia of unknown significance; CIS, urothelial carcinoma in situ; EIHGUC, early infiltrating high-grade urothelial carcinoma (pT1); NIHGpUC, noninfiltrating high-grade papillary urothelial carcinoma; NILGpUC, noninfiltrating low-grade papillary urothelial carcinoma; RA, reactive atypia. * 1, Mild cellular atypia (probably benign); 2, moderate cellular atypia (indeterminate for malignancy); 3, severe cellular atypia (suggestive of malignancy); 4, malignancy.
† Scoring was as follows: negative (0), no discernible staining or fewer than 5% positive cells; 1+, 5%-20% positive cells; 2+, 21%-70% positive cells; 3+, more than 71% positive cells with strong intensity in the nuclei and cytoplasm.
high-grade tumors, showed a lower incidence of p16 INK4a overexpression than noninfiltrating high-grade tumors. The mechanism of p16 INK4a overexpression can be explained in 2 ways. One is that increased p16 INK4a gene expression caused by polyploidy of chromosome 9 or amplification of the 9p21 locus can augment directly protein expression. Another explanation is the self-regulation that accompanies abnormally high levels of cell proliferation, namely, p16 INK4a protein with a very long half-life accumulates in cells and down-regulates proliferation. 43 Self-regulation of p16 INK4a overexpression is best known in uterine cervical tumors with human papillomavirus infection. The binding of E6 and E7 oncoproteins of the human papillomavirus to p53 and Rb proteins inhibits the suppressor function of cell proliferation and, methylation of 5′ CpG islands, and mutations of the p16 INK4a gene have been reported in 0% to 66%, 15% to 67%, and 0% to 7% of urothelial carcinomas, respectively, as causes of loss of p16 INK4a expression. [21] [22] [23] [37] [38] [39] [40] [41] [42] On the other hand, expression of p16 INK4a protein has been reported in 11% to 100% of urothelial carcinomas. [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] In the present study, nonneoplastic lesions such as normal urothelium and atypia of unknown significance showed only weak expression of p16 INK4a , whereas 3 (25%) of 12 cases of reactive atypia after BCG therapy and 70 (47.6%) of 147 neoplastic lesions such as dysplasia and urothelial carcinoma revealed overexpression of p16 INK4a . In particular, CIS showed a high incidence (70%) of p16 INK4a overexpression. It is interesting that advanced infiltrating carcinomas, even consequently, induces overexpression of p16 INK4a for selfregulation of cell proliferation. [14] [15] [16] [17] [18] [19] [20] 44 In urothelial carcinoma, one study reported polysomy of chromosome 9 as the cause of p16 INK4a overexpression. 21 However, another study using FISH analysis showed a very low incidence of polysomy of chromosome 9 and a high incidence of deletion of the 9p21 locus in infiltrating carcinomas (data not shown). Based on the preceding discussion, we conclude that the main cause of p16 INK4a overexpression in reactive atypia after BCG therapy and urothelial carcinoma is self-regulation of abnormally high cell proliferation, and the lower incidence of p16 INK4a overexpression in infiltrating cases results from deletion of the 9p21 locus.
No previous study has evaluated the validity of p16 INK4a expression analysis for urinary cytologic diagnosis. In the present study, the sensitivity of detection of p16 INK4a expression in cytologic samples was similar to that in histologic sections. Weak expression but not overexpression of p16 INK4a was found in cells in group 1 (mild cellular atypia), while p16 INK4a overexpression was found in 16%, 42%, and 50% of cases in groups 2 (indeterminate for malignancy), 3 (suspicious of malignancy), and 4 (malignancy), respectively. Unfortunately, we could not compare histologic diagnosis and p16 INK4a expression in most cases in group 2; however, 5 cases with p16 INK4a overexpression in group 2, which were histologically examined, were all malignant. All cytologic samples with p16 INK4a overexpression were confirmed to be neoplastic by histologic diagnosis. We consider that overexpression of p16 INK4a in indeterminate or suspicious cases is a useful finding for confirming malignancy in cytology. Also, cytologic samples with p16 INK4a overexpression had a high incidence (80%) of high-grade urothelial carcinoma. High-grade urothelial carcinoma did not always show a sufficient number of cells with marked atypia in cytologic samples, and it was often difficult to make a differential cytologic diagnosis of benign or low-grade lesions as shown in Table 3 ; therefore, p16 INK4a overexpression in indeterminate or suspicious cases was a useful marker of high-grade malignancy. Moreover, 57% of cytologic cases with negative p16 INK4a expression in group 4 probably resulted from deletion of the 9p21 locus and were infiltrating carcinomas. This suggests that malignancy with marked cellular atypia and negative p16 INK4a expression in cytologic samples may be an indicator of stromal invasion.
From a prognostic viewpoint, it is important to detect, as early as possible, high-grade malignant lesions in the urinary bladder that have stromal invasion or high potential of invasion. Immunocytologic analysis of p16 INK4a expression in cytologic samples is a useful ancillary tool for detecting urothelial carcinoma and infiltrating potential. 
